Joachim Stangier
Impact in
- Internal Medicine top 0.05%
- Venous Thromboembolism Diagnosis and Management
-
- Atrial Fibrillation Management and Outcomes
- Cardiac Arrhythmias and Treatments
- Antiplatelet Therapy and Cardiovascular Diseases
- Blood Pressure and Hypertension Studies
Papers in
-
- Atrial Fibrillation Management and Outcomes 40
- Acute Myocardial Infarction Research 9
- Blood Pressure and Hypertension Studies 8
- Cardiac Arrhythmias and Treatments 6
- Renin-Angiotensin System Studies 6
-
- Venous Thromboembolism Diagnosis and Management 17
- Co-authors
- Karin Rathgen (9 shared papers)Hildegard Stähle (7 shared papers)Andreas Clemens (8 shared papers)Willy Roth (6 shared papers)Martin Feuring (4 shared papers)Joanne van Ryn (12 shared papers)Wolfgang Wienen (5 shared papers)Dietmar Ganßer (9 shared papers)
- Journals
- The Journal of Clinical Pharmacology (12 papers)Thrombosis and Haemostasis (6 papers)Clinical Pharmacokinetics (4 papers)Circulation (3 papers)British Journal of Clinical Pharmacology (3 papers)
- Partner nations
- GermanyUnited StatesNetherlands
In The Last Decade
Joachim Stangier
67 papers receiving 8.8k citations
Joachim Stangier's Hit Papers
Peers
Comparison fields: 5 of 129
- Internal Medicine 4.7k
- Cardiology and Cardiovascular Medicine 7.2k
- Hematology 853
- Pharmacology 410
- Toxicology 150
Countries citing papers authored by Joachim Stangier
This map shows the geographic impact of Joachim Stangier's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Joachim Stangier with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Joachim Stangier more than expected).
Fields of papers citing papers by Joachim Stangier
This network shows the impact of papers produced by Joachim Stangier. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Joachim Stangier. The network helps show where Joachim Stangier may publish in the future.
Co-authors
The 25 scholars most cited alongside Joachim Stangier, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 67 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Dabigatran etexilate – a novel, reversible, oral direct thrombin inhibitor: Interpretation of coagulation assays and reversal of anticoagulant activity Hit paper breakdown → | 2010 | 1026 |
| 2 | Idarucizumab for Dabigatran Reversal Hit paper breakdown → | 2015 | 981 |
| 3 | The pharmacokinetics, pharmacodynamics and tolerability of dabigatran etexilate, a new oral direct thrombin inhibitor, in healthy male subjects Hit paper breakdown → | 2007 | 693 |
| 4 | Influence of Renal Impairment on the Pharmacokinetics and Pharmacodynamics of Oral Dabigatran Etexilate Hit paper breakdown → | 2010 | 551 |
| 5 | The Metabolism and Disposition of the Oral Direct Thrombin Inhibitor, Dabigatran, in Humans Hit paper breakdown → | 2007 | 549 |
| 6 | Clinical Pharmacokinetics and Pharmacodynamics of the Oral Direct Thrombin??Inhibitor Dabigatran Etexilate Hit paper breakdown → | 2008 | 520 |
| 7 | 2008 | 339 | |
| 8 | 2007 | 332 | |
| 9 | 2004 | 321 | |
| 10 | 2009 | 272 | |
| 11 | 2005 | 241 | |
| 12 | 2015 | 237 | |
| 13 | 2012 | 225 | |
| 14 | 2000 | 219 | |
| 15 | 1987 | 185 | |
| 16 | 2015 | 183 | |
| 17 | 2000 | 173 | |
| 18 | 2010 | 169 | |
| 19 | 2004 | 160 | |
| 20 | 2008 | 142 |
About Joachim Stangier
Joachim Stangier is a scholar working on Cardiology and Cardiovascular Medicine, Internal Medicine, Surgery, Hematology and Molecular Biology, having authored 67 papers that have together received 9.2k indexed citations. Recurring topics across this work include Atrial Fibrillation Management and Outcomes (40 papers), Venous Thromboembolism Diagnosis and Management (17 papers), Blood Coagulation and Thrombosis Mechanisms (11 papers), Heparin-Induced Thrombocytopenia and Thrombosis (10 papers), Acute Myocardial Infarction Research (9 papers), Blood Pressure and Hypertension Studies (8 papers), Cardiac Arrhythmias and Treatments (6 papers) and Renin-Angiotensin System Studies (6 papers). The work is most often cited by research in Internal Medicine (4.7k citations), Cardiology and Cardiovascular Medicine (7.2k citations), Hematology (853 citations), Pharmacology (410 citations) and Toxicology (150 citations). Joachim Stangier has collaborated with scholars based in Germany, United States and Netherlands. Frequent co-authors include Karin Rathgen, Hildegard Stähle, Andreas Clemens, Willy Roth, Martin Feuring, Joanne van Ryn, Wolfgang Wienen, Dietmar Ganßer, Karl‐Heinz Liesenfeld and Sebastian Haertter. Their work appears in journals such as The Journal of Clinical Pharmacology, Thrombosis and Haemostasis, Clinical Pharmacokinetics, Circulation and British Journal of Clinical Pharmacology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.